Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niantong Qufeng granules for acute gouty arthritis
ChiCTR2400083191Phase 3Completed
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Apr 2024
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of niantong qufeng granules in acute gout flare (2 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoint: Time to disappearance of joint pain. Started Apr 2024; status: completed.
02
Drugs
niantong qufeng granules
03
Conditions
acute gout flare
Beyond the preview
Go deeper on ChiCTR2400083191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083191.